Access cutting-edge hemophilia treatment through this clinical trial at a research site in Washington Dc. Study-provided care at no cost to qualified participants.
Access hemophilia specialists in Washington Dc at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hemophilia treatment provided free
Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding event (BE), or who are not on prophylactic treatment who may need to control a BE.
Sponsor: American Thrombosis and Hemostasis Network
Check if you qualify for this hemophilia clinical trial in Washington Dc, DC
If you're searching for hemophilia treatment options in Washington Dc, DC, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Washington Dc research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hemophilia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.